Siteman Advantage

Fact: The Siteman Cancer Center is the only National Cancer Institute-designated Comprehensive Cancer Center in Missouri and is ranked among the top cancer facilities in the nation by U.S. News & World Report.

What this means for you: We provide a full range of cancer diagnosis and treatment options led by specialists at the top of their field, many involved in leading-edge research on novel therapies.

Fact: Our physicians treat an average of 200 new bladder cancer cases each year.

What this means for you: This experience in the treatment of bladder cancer comes with cutting edge diagnostic and treatment options you won’t find in most medical centers.

Fact: Siteman pioneered the development of genomic testing for personalized, targeted treatment. Treatment is targeted to the genetic components of the cancer.

What this means for you: Knowing the genetic make-up of your cancer yields important information about which treatments may be more effective and what won’t work, which means less exposure to ineffective treatments.

Fact: Multidisciplinary care teams at Siteman provide nationally recognized expertise in the diagnosis and treatment of your cancer.

What this means for you: In short, your doctors talk to each other, face-to-face, on a weekly basis and plan the right care for you and your specific cancer.

Fact: Siteman has the most clinical trials in the region and our treatment teams frequently recommend a promising trial as a first-line treatment.

What this means for you: The standard of care at a research hospital is often clinical trials, meaning you get treatments not otherwise available.

Fact: This team is the most experienced in the world in performing nerve-sparing bladder removal and construction of new bladders that preserve urinary continence in both men and women with bladder cancer.

What this means for you: You continue to urinate normally while preserving sexual potency and comfort with intercourse.

Fact: Siteman’s radiation oncology team is a pioneer in developing methods that target pelvic tumors and avoid radiation damage to surrounding normal tissue with strategies that are tailored to each patient’s needs.

What this means for you: By using MRI to help guide radiation therapy treatments in real time, your team can see where the radiation dose is being delivered and if subtle changes are occurring to the tumor or surrounding tissue, adjusting dosage as needed.